Response surface methodological approach for optimization of photodynamic therapy of onychomycosis using chlorin e6

Ghada Yasin1, Maha Nasr2, Sara A Abdel Gaber3

  • 1Pharmaceutical Nano-Technology Laboratory, Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences (NILES), Cairo University, Cairo, Egypt.

Insights

Antimicrobial photodynamic inactivation (aPDI) offers a new way to treat nail fungus. Researchers developed Chorin e6-containing vesicles (Ce6-nPEVs) that improve drug delivery into nails, showing promise for onychomycosis treatment.

Area of Science:

  • Pharmaceutical Sciences
  • Dermatology
  • Photomedicine

Background:

  • Onychomycosis, a fungal nail infection, is difficult to treat due to the nail barrier.
  • Conventional antifungals have limited efficacy against deep-seated nail fungi.
  • Antimicrobial photodynamic inactivation (aPDI) is a promising alternative therapy.

Purpose of the Study:

  • To prepare, optimize, and characterize Chorin e6 (Ce6) nail penetration enhancer containing vesicles (Ce6-nPEVs).
  • To evaluate the photodynamic efficacy of Ce6-nPEVs against Trichophyton rubrum, a common cause of onychomycosis.
  • To assess the transungual delivery potential of Ce6-nPEVs compared to free Ce6.

Main Methods:

  • Formulation optimization using a full factorial design for particle size and encapsulation efficiency.
  • Characterization of Ce6-nPEVs for particle size, zeta potential, and viscosity.
  • Assessment of nail penetration and hydration enhancement.
  • Optimization of aPDI conditions for T. rubrum using response surface methodology (Box-Behnken design).
  • In vitro evaluation of aPDI efficacy of Ce6-nPEVs versus free Ce6.

Main Results:

  • Optimized Ce6-nPEVs exhibited high encapsulation efficiency (79.4-98%) and suitable physical properties (particle size 225-859 nm, zeta potential +30 to +70 mV).
  • The selected formulation significantly enhanced nail hydration (1.8-fold) and Ce6 uptake (2.3-fold) compared to free Ce6.
  • Both free Ce6 and Ce6-nPEVs demonstrated equipotent in vitro fungicidal effects against T. rubrum under optimized conditions.

Conclusions:

  • Ce6-nPEVs effectively enhance nail penetration and hydration, addressing key challenges in onychomycosis treatment.
  • The optimized formulation shows potential for improved in vivo therapeutic outcomes in aPDI for onychomycosis.
  • Further in vivo studies are warranted to demonstrate the clinical advantage of enhanced nail penetration.

Related Concept Videos